🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT02420470
Recruiting Observational

The Early Warning System for the Diabetic Encephalopathy

NCT02420470 · tracked via the Priya Life Science China tracker
Sponsor
Tang-Du Hospital
Phase
Observational
Started
2015-04
Last updated
2022-07-13

Condition(s) studied

Diabetes Mellitus Type 2Mild Cognitive ImpairmentMetabolic Syndrome X

Study summary

Diabetes( mainly type II diabetes )lead to the central nervous system (CNS) function impairment, especially the mild cognitive impairment that increased the risk of progression to dementia.The primary objectives are defined according to a hierarchical design: i) to tailor and apply multi-parametric, functional MRI techniques to identify cerebral abnormalities (cerebral biomarkers) in type 2 diabetes mellitus and prodromal diabetes mellitus ; ii) to assess whether these cerebral biomarkers are associated with cognitive decrements;iii) to follow up with the putative prediabetic condition patients to verify whether they can transform into diabetes.

Eligibility

Sex
ALL
Min age
40 Years
Max age
65 Years
Healthy volunteers
Accepted
Inclusion Criteria: * without dementia * Inform Consent Form * Education time more than 6 years * blood glucose matches the group standard Exclusion Criteria: * Pregnant woman * suffer from serious brain disease * Magnetic resonance contraindications * lack of compliance * image quality is too poor to deal with

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Tangdu Hospital Xi'an Shaanxi Recruiting

More Tang-Du Hospital trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT02420470 on ClinicalTrials.gov ↗ ← All trials in China